ACC Highlights 2020 - What You Need To Know
Details & Video

Program details and agenda: Select TABS on the left (computer) or SCROLL DOWN (phone)
Overview & Objectives
This program will cover the key clinical trial findings and their implications from ACC 2020. This program is intended for cardiovascular specialists and primary care physicians from across Canada.
Accreditation
This program is NOT accredited.
Mainpro+ participants may earn certified credits by completing a Linking Learning Exercise.
Specialist participants may claim Section 2 credits (up to 2 credits per hour) following completion of a personal learning project (PLP) under Section 2: Self-Learning Activities within the MAINPORT ePortfolio.
You will receive a Certificate of Attendance for your records following completion of the session evaluation form.
Faculty
Faculty

Associate Clinical Professor of Medicine,
McMaster University
Medical Director
Canadian Collaborative Research Network
View disclosures

Director, Clinical Research Atlanta Heart Specialists
Clinical Assistant Professor,
Medical College of Georgia at Augusta University
Clinical Assistant Professor
Georgia Regents University

Executive Director, Interventional
Cardiovascular Programs,Brigham and
Women’s Hospital Heart & Vascular Center
Professor of Medicine Harvard Medical School
Agenda
Agenda
Program Chapter | Duration (Min:Sec) |
---|---|
Heart Failure | |
- VICTORIA | |
- New data from PARAGON-HF | |
Peripheral artery disease | |
- VOYAGER-PAD | |
- COMPASS DM | |
Lipids | |
- Homozygous FH | |
- EPA levels in REDUCE-IT | |
- New data from ODYSSEY Outcomes | |
- Evolocumab for HIV patients | |
Structural heart disease | |
- Updates in TAVR |
Sponsorship
This program has been developed by the Canadian Collaborative Research Network, a not-for-profit physician organization, and is supported through an educational grant received from:
GOLD SPONSORS
Amgen Canada Inc.
Bayer Canada
SILVER SPONSORS
HLS Therapeutics
Sanofi Canada
BRONZE SPONSORS
Bristol Meyers Squibb